SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-15-001071
Filing Date
2015-03-30
Accepted
2015-03-30 17:23:23
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1102940
2 ex21.htm EX-21 1416
3 ex23-1.htm EX-23.1 4312
4 ex31-1.htm EX-31.1 15912
5 ex31-2.htm EX-31.2 15849
6 ex32.htm EX-32 8748
  Complete submission text file 0001493152-15-001071.txt   8534473

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE corx-20141231.xml EX-101.INS 812086
8 XBRL SCHEMA FILE corx-20141231.xsd EX-101.SCH 72653
9 XBRL CALCULATION FILE corx-20141231_cal.xml EX-101.CAL 56667
10 XBRL DEFINITION FILE corx-20141231_def.xml EX-101.DEF 327727
11 XBRL LABEL FILE corx-20141231_lab.xml EX-101.LAB 514985
12 XBRL PRESENTATION FILE corx-20141231_pre.xml EX-101.PRE 403378
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16467 | Film No.: 15735557
SIC: 2834 Pharmaceutical Preparations